Home > Francesco Bandello, ESCRS 2020 – Anti-vascular Endothelial Growth Factor Agents and Laser for Treatment of Proliferative Diabetic Retinopathy
Diabetic Retinopathy

Francesco Bandello, ESCRS 2020 – Anti-vascular Endothelial Growth Factor Agents and Laser for Treatment of Proliferative Diabetic Retinopathy

Published Online: October 12th 2020

It was a pleasure to catch up with our Editorial Board member, Prof. Francesco Bandello (University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy), who talked us through his recent research on anti-vascular endothelial growth factor agents combined with laser for the treatment of proliferative diabetic retinopathy.

Questions

  1. Could you tell us a little about your recent research on the treatment of proliferative diabetic retinopathy with a combination of anti-VEGF agents and laser? (00:07)
  2. What has been the impact of the COVID-19 pandemic on Ophthalmology care and research? (03:40)

Speaker Disclosures: Prof. Francesco Bandello discloses the following relationships: Allergan, Bayer, Boehringer-Ingelheim, Fidia Sooft, Hofmann La Roche, Novartis, NTC Pharma, SiFi, Thrombogenics, Zeiss

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of ESCRS 2020.

Share this Video
Related Videos In Diabetic Retinopathy
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar